BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kondakova OA, Nikitin NA, Evtushenko EA, Ryabchevskaya EM, Atabekov JG, Karpova OV. Vaccines against anthrax based on recombinant protective antigen: problems and solutions. Expert Rev Vaccines 2019;18:813-28. [PMID: 31298973 DOI: 10.1080/14760584.2019.1643242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Granovskiy DL, Ryabchevskaya EM, Evtushenko EA, Kondakova OA, Arkhipenko MV, Kravchenko TB, Bakhteeva IV, Timofeev VS, Nikitin NA, Karpova OV. New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses. Front Microbiol 2022;13:1003969. [DOI: 10.3389/fmicb.2022.1003969] [Reference Citation Analysis]
2 Kondakova OA, Evtushenko EA, Baranov OA, Nikitin NA, Karpova OV. Structurally Modified Plant Viruses and Bacteriophages with Helical Structure. Properties and Applications. Biochemistry Moscow 2022;87:548-558. [DOI: 10.1134/s0006297922060062] [Reference Citation Analysis]
3 Ryabchevskaya EM, Granovskiy DL, Evtushenko EA, Ivanov PA, Kondakova OA, Nikitin NA, Karpova OV. Designing Stable Bacillus anthracis Antigens with a View to Recombinant Anthrax Vaccine Development. Pharmaceutics 2022;14:806. [DOI: 10.3390/pharmaceutics14040806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ali Dahhas M, Alsenaidy MA. Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.02.011] [Reference Citation Analysis]
5 Gün N. Brief overview of anthrax vaccines: Current and future developments. International Journal of Life Sciences and Biotechnology 2021. [DOI: 10.38001/ijlsb.969607] [Reference Citation Analysis]
6 Kelly SM, Larsen KR, Darling R, Petersen AC, Bellaire BH, Wannemuehler MJ, Narasimhan B. Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis. Vaccine 2021;39:3862-70. [PMID: 34090702 DOI: 10.1016/j.vaccine.2021.05.077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Ryabchevskaya EM, Evtushenko EA, Granovskiy DL, Ivanov PA, Atabekov JG, Kondakova OA, Nikitin NA, Karpova OV. Two approaches for the stabilization of Bacillus anthracis recombinant protective antigen. Hum Vaccin Immunother 2021;17:560-5. [PMID: 32614657 DOI: 10.1080/21645515.2020.1772632] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Evtushenko EA, Ryabchevskaya EM, Nikitin NA, Atabekov JG, Karpova OV. Plant virus particles with various shapes as potential adjuvants. Sci Rep 2020;10:10365. [PMID: 32587281 DOI: 10.1038/s41598-020-67023-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
9 Savransky V, Ionin B, Reece J. Current Status and Trends in Prophylaxis and Management of Anthrax Disease. Pathogens 2020;9:E370. [PMID: 32408493 DOI: 10.3390/pathogens9050370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kumar M, Puranik N, Varshney A, Tripathi N, Pal V, Goel AK. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model. J Appl Microbiol 2020;129:443-52. [PMID: 32118336 DOI: 10.1111/jam.14624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 de Oliveira FFM, Mamillapalli S, Gonti S, Brey RN, Li H, Schiffer J, Casadevall A, Bann JG. Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice. mSphere 2020;5:e00556-19. [PMID: 31941807 DOI: 10.1128/mSphere.00556-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ryabchevskaya E, Evtushenko E, Nikitin N, Kondakova O, Ivanov P, Karpova O. DEVELOPMENT OF STABLE ANTHRAX ANTIGEN FOR PLANT VIRUS-BASED VACCINE. BIOTECHNOLOGY: STATE OF THE ART AND PERSPECTIVES 2020. [DOI: 10.37747/2312-640x-2020-18-200-202] [Reference Citation Analysis]